Can only be harmful with the likelihood of a misdiagnosis. Obviously the test results made it more likely to be harmful than not.....why didn't Experien see this with all their experience and 99% success rate? They have a lot to answer for. I'm gutted.
- Forums
- ASX - By Stock
- RAP
- Ann: Update on US FDA De Novo Classification Request
Ann: Update on US FDA De Novo Classification Request, page-10
-
-
- There are more pages in this discussion • 308 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)